In the United States, Eisai’s major products are LENVIMA® (lenvatinib), HALAVEN® (eribulin mesylate), FYCOMPA® (perampanel) and DAYVIGO™ (lemborexant). We aim to drive ongoing growth here in the world’s biggest pharmaceutical market by expanding these global brands.
Eisai hires marketing professionals with varying levels of pharmaceutical experience to join us in optimizing sales, patient share and revenue growth in alignment with established goals and targets. Depending on your role, you may also be responsible for developing, implementing and executing short- and long-term brand strategies, including pre-launch and launch plans.
We look for confident brand champions who have a track record of success in collaborating with
teams. You should also have a demonstrated understanding of pharmaceutical industry regulations, current
market trends, and the U.S. healthcare environment.